Eli Lilly Corp. buy Scotiabank
Start price
05.02.26
/
50%
€875.30
Target price
05.02.27
-
Performance (%)
21.63%
Price
09:12
€1,064.6
Summary
This prediction is currently active. The prediction currently has a performance of 21.63%. This prediction currently runs until 05.02.27. The prediction end date can be changed by Scotiabank at any time. Scotiabank has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Eli Lilly Corp. | 9.496% | 9.496% |
| iShares Core DAX® | 1.001% | 4.831% |
| iShares Nasdaq 100 | 2.702% | -1.720% |
| iShares Nikkei 225® | 3.519% | -3.506% |
| iShares S&P 500 | 1.766% | 1.273% |
Comments by Scotiabank for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE:LLY) had its "outperform" rating reaffirmed by analysts at Scotiabank.
Ratings data for LLY provided by MarketBeat

